Coherus Biosciences reported $-38528000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Amarin AMRN:US $ -12.97M 21.83M
Baxter International BAX:US $ 608M 107M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Bristol Myers Squibb BMY:US $ 5289M 67M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Fujifilm 4901:JP Y 52117M 25667M
LG Chem 051910:KS KW 737504M 1564748M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Teva Pharmaceutical TEVA:IT 382M 412M
Xencor XNCR:US $ -40.19M 92.44M
Zoetis ZTS:US $ 717M 11M